Global surgical robotics company, CMR Surgical (CMR), has announced plans to build a new global manufacturing facility in Cambridgeshire, UK. The site will enable upscaled manufacturing processes to meet the increasing global demand for the Versius® Surgical Robotic System, now established as a valuable surgical tool in a number of hospitals across Europe, India, Australia and the Middle East.
Following the recent completion of the largest-ever MedTech private financing round worldwide, CMR remains focused on the ongoing commercial scale up of Versius and the building of its manufacturing capability will help to support this. Alongside this, CMR is committed to investing in future technology developments for Versius and its digital ecosystem that will benefit surgeons and improve surgical care on a global scale.
The new facility will span 7,044.8 sq. m. (75,832 sq. ft.) floor space and will house up to 200 skilled employees initially from production, quality, manufacturing engineering, supply, operations, and logistics. The site will be located in Ely, close to the Company’s headquarters in Cambridge.
Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, commented: “We continue to see strong demand for Versius in markets around the world and our commitment to building a new manufacturing facility reflects this whilst highlighting the scale of our ambition to transform surgery. The workforce in Cambridgeshire will be crucial in helping us deliver systems to benefit patients in all corners of the world and we see this as an important development in our company growth strategy.”
Barrington D’Arcy, Chief Operations Officer of CMR Surgical, said: “Establishing a world-class manufacturing facility to meet worldwide demand was a logical step forward for CMR. Connecting in proximity our skilled workforce from manufacturing, R&D, supply and other important functions means that we can bring together the strongest talent to deliver the commercial production upscale for Versius.”
CMR has more than 700 employees working in R&D, clinical, manufacturing, supply chain, commercial, and service.
This investment in the UK strengthens CMR’s role in shaping innovation through surgical robotics to improve surgical care.
Source: CMR Surgical.